Medtronic plc MDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...
New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System DUBLIN, May 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...
DUBLIN- February 26, 2018 - Medtronic plc (MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved a new arm indication for the ...
DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...
Roughly 1.25 million Americans have Type 1 diabetes, so chances are you know somebody whose pancreas is taking the world’s longest lunch break. That person may be you. As it happens, there has never ...
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S ...
Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...
DUBLIN, May 26, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback